Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance-Reference-Cited by-同舟云学术

Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance

Published:2015-03-30 Issue:3 Volume:10 Page:e0121912
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chendamarai Ezhilarasi,Ganesan Saravanan,Alex Ansu Abu,Kamath Vandana,Nair Sukesh C.,Nellickal Arun Jose,Janet Nancy Beryl,Srivastava Vivi,Lakshmi Kavitha M.,Viswabandya Auro,Abraham Aby,Aiyaz Mohammed,Mullapudi Nandita,Mugasimangalam Raja,Padua Rose Ann,Chomienne Christine,Chandy Mammen,Srivastava Alok,George Biju,Balasubramanian Poonkuzhali,Mathews Vikram

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. Updates on the treatment of acute promyelocytic leukemia;MS Tallman;Clin Adv Hematol Oncol,2010

2. Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence;MA Sanz;Haematologica,2005

3. The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment;F Lo-Coco;Hematology Am Soc Hematol Educ Program,2006

4. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid;TR Breitman;Blood,1981

5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients;ZX Shen;Blood,1997

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia;Scientific Reports;2024-04-10

3. miR-603 promotes cell proliferation and differentiation by targeting TrkB in acute promyelocytic leukemia;Annals of Hematology;2023-09-19

4. Optimizing Arsenic Therapy by Selectively Targeting Leukemia Cells;Journal of Medicinal Chemistry;2023-08-18

5. PML mutants resistant to arsenic induced degradation fail to generate the appropriate SUMO and ubiquitin signals required for RNF4 and p97 recruitment;2023-01-17